VF
ONC icon

Virtu Financial’s BeOne Medicines Ltd ONC Stock Holding History

Virtu Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,319
Closed -$959K – 2220
2023
Q4 		$959K Buy
5,319
+2,580
+94% +$467K 0.08% 210
2023
Q3 		$493K Sell
2,739
-2,830
-51% -$560K 0.05% 355
2023
Q2 		$993K Buy
+5,569
New +$1.28M 0.08% 209
2022
Q3 		– Sell
-9,758
Closed -$1.58M – 2324
2022
Q2 		$1.58M Buy
+9,758
New +$1.52M 0.13% 129
2021
Q3 		– Sell
-3,622
Closed -$1.24M – 2058
2021
Q2 		$1.24M Buy
+3,622
New +$1.2M 0.12% 144
2019
Q4 		$740K Buy
+4,462
New +$741K 0.07% 301
2018
Q3 		– Sell
-3,455
Closed -$531K – 2322
2018
Q2 		$531K Buy
+3,455
New +$616K 0.03% 761
2017
Q4 		– Sell
-3,777
Closed -$391K – 3116
2017
Q3 		$391K Buy
+3,777
New +$281K 0.02% 1132

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Virtu Financial's ONC Position: Q1 2024 in Review

Virtu Financial sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 5,319 shares — an estimated $959K sold.

Virtu Financial first reported a position in ONC in Q3 2017 and held it in 8 quarters. The position peaked at $1.58M in Q2 2022. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Virtu Financial reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 5,319 BeOne Medicines Ltd shares in Q1 2024, an estimated $959K.
  • Virtu Financial first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's BeOne Medicines Ltd position peaked at $1.58M in Q2 2022.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.